Medtronic Enrolls First Patient in Study of IN.PACT(TM) AV Access Drug-Coated Balloon in Patients with End-Stage Renal Disease
Go back to Medtronic Enrolls First Patient in Study of IN.PACT(TM) AV Access Drug-Coated Balloon in Patients with End-Stage Renal Disease| Medtronic Inc. (NYSE: MDT) | Delayed: 80.63 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $80.63 | 52 Week High | $89.27 | |||
| Open | $80.63 | 52 Week Low | $71.03 | |||
| Day High | $80.63 | P/E | 22.91 | |||
| Day Low | $80.63 | EPS | $3.52 | |||
| Volume | 1,545 | |||||
